Mereo BioPharma Group PLC (MREO)
3.145
+0.18
(+6.25%)
USD |
NASDAQ |
May 15, 15:53
Mereo BioPharma Group Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
Biodexa Pharmaceuticals Plc | -- |
NuCana PLC | 0.4825M |
TC BioPharm (Holdings) PLC | -- |
Adaptimmune Therapeutics PLC | -14.68M |
Autolus Therapeutics PLC | -24.83M |
Cash from Operations (Quarterly) Related Metrics
Free Cash Flow | -21.55M |
Free Cash Flow Yield | -5.20% |